Regulation of arginase expression by T-helper II cytokines and isoproterenol

被引:45
作者
Barksdale, AR
Bernard, AC
Maley, ME
Gellin, GL
Kearney, PA
Boulanger, BR
Tsuei, BJ
Ochoa, JB
机构
[1] Univ Kentucky, Dept Surg, Coll Med, Lexington, KY 40536 USA
[2] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Dept Crit Care, Pittsburgh, PA 15260 USA
关键词
D O I
10.1016/j.surg.2003.10.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Trauma causes a release of catecholamines, transforming growth factor-beta (TGF-beta), and T-helper II cytokines (TH2). Individually, these substances also induce arginase in macrophages. The purpose of this study was to determine the synergistic interactions between isoproterenol, TGF-beta, and TH2 cytokines on arginase expression in macrophages. Methods. Confluent RAW 264.7 macrophages were incubated with various combinations of interleukins 4, 10, and 13 (IL-4, IL-10, IL-13), and TGF-beta with isoproterenol over 48 hours. Arginase activity, as well as arginase I expression by Western blot and reverse transcriptase-polymerase chain reaction, were measured. Results. Although isoproterenol, IL-4, IL-10, and IL-13 individually induced arginase, significant synergy between the combination of isoproterenol with either TGF-beta or the TH2 cytokines was observed. All cytokines except IL-10 also induced arginase I protein and mRNA. Arginase II protein was detected in cells exposed to IL-10. Conclusions. We conclude that isoproterenol synergizes with IL-4, IL-13, and TGF-P to increase arginase I mRNA and protein, as well as arginase activity in RAW 264.7 macrophages. Further, IL-10 synergizes with isoproterenol to increase arginase activity and arginase 11 protein. These synergistic mechanisms may compete with nitric oxide synthase for L-arginine substrate, thus shunting away available arginine from nitric oxide production and contributing to cellular immunosuppression observed after trauma.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 41 条
  • [1] Catecholaminergic suppression of immunocompetent cells
    Bergquist, J
    Tarkowski, A
    Ewing, A
    Ekman, R
    [J]. IMMUNOLOGY TODAY, 1998, 19 (12): : 562 - 567
  • [2] Beta adrenoceptor regulation of macrophage arginase activity
    Bernard, AC
    Fitzpatrick, EA
    Maley, ME
    Gellin, GL
    Tsuei, J
    Arden, WA
    Boulanger, BR
    Kearney, PA
    Ochoa, JB
    [J]. SURGERY, 2000, 127 (04) : 412 - 418
  • [3] Alterations in arginine metabolic enzymes in trauma
    Bernard, AC
    Mistry, SK
    Morris, SM
    O'Brien, WE
    Tsuei, BJ
    Maley, ME
    Shirley, LA
    Kearney, PA
    Boulanger, BR
    Ochoa, JB
    [J]. SHOCK, 2001, 15 (03): : 215 - 219
  • [4] BOUTARD V, 1995, J IMMUNOL, V155, P2077
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study
    Braissant, O
    Gotoh, T
    Loup, M
    Mori, M
    Bachmann, C
    [J]. MOLECULAR BRAIN RESEARCH, 1999, 70 (02): : 231 - 241
  • [7] NUTRITIONAL PHARMACOLOGY - EFFECTS OF L-ARGININE ON HOST DEFENSES, RESPONSE TO TRAUMA AND TUMOR-GROWTH
    BRITTENDEN, J
    HEYS, SD
    ROSS, J
    PARK, KGM
    EREMIN, O
    [J]. CLINICAL SCIENCE, 1994, 86 (02) : 123 - 132
  • [8] IL-4 and IL-13 receptors: Are they one and the same?
    Callard, RE
    Matthews, DJ
    Hibbert, L
    [J]. IMMUNOLOGY TODAY, 1996, 17 (03): : 108 - 110
  • [9] Differential expression of arginase and iNOS in the lung in sepsis
    Carraway, MS
    Piantadosi, CA
    Jenkinson, CP
    Huang, YCT
    [J]. EXPERIMENTAL LUNG RESEARCH, 1998, 24 (03) : 253 - 268
  • [10] The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: Its implications in IL-13-inhibited nitric oxide production
    Chang, CI
    Zoghi, B
    Liao, JC
    Kuo, L
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (04) : 2134 - 2141